You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening. Financial terms of the deal were not disclosed.
NEW YORK (GenomeWeb News) – Compugen and DiscoveRx today announced a collaboration to commercialize specially designed peptides matched with specific G protein-coupled receptor targets.
By Adam Bonislawski
Two papers published in the current edition of Nature Biotechnology add significantly to the publicly available data on the specificity of kinase inhibitors.
Starting in the first quarter of 2011, DiscoveRx plans to add its own panel of cell-based assays to the KinomeScan service as an offering.
The co-marketing agreement will give Jubilant’s drug developer customers cell-based screening services.
BioFocus will offer DiscoveRx's GPCR and cAMP assays as part of its screening services.
DiscoveRx will provide GSK with access to its beta-arresting parental cell lines, clones, and associated reagents.
AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.
Time magazine looks into how liquid biopsies are changing cancer care.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.